[<sup>18</sup>F]FDG PET/CT volumetric biomarkers for non-invasive prediction of HER2 expression in breast cancer patients.

导出 LinkOut

翻译打印收藏纠错

作者： Mai Amr,Elahmadawy ^[1] ; Heba,Abdelhamed ^[2] ; Dina Hosny,Gamal El-Din ^[3] ; Mahitab,Eltohamy ^[4] ; Adel Mohamed,Ismail Hassan ^[5] ; Salwa,Abd El-Gaid ^[1]

作者单位： Nuclear Medicine Unit, National Cancer Institute (NCI), Cairo University, Cairo, Egypt. ^[1] Clinical oncology and nuclear medicine department, Zagazig University, Zagazig Egypt. ^[2] Radiology department , Kasr Al Aini medical school, Cairo University, Cairo, Egypt. ^[3] Pathology department, National Cancer Institute (NCI), Cairo University, Cairo, Egypt. ^[4] Surgical Oncology department, Ismailia teaching oncology hospital, Ismailia, Egypt. ^[5]

关键词 Breast cancer HER2 PET/CT

DOI 10.22038/aojnmb.2024.79970.1563

PMID 39744060

发布时间 2025-01-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Asia Oceania journal of nuclear medicine & biology

2025年13卷1期

10-20页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

[<sup>18</sup>F]FDG PET/CT volumetric biomarkers for non-invasive prediction of HER2 expression in breast cancer patients.

Asia Oceania journal of nuclear medicine & biology

相似文献

Asia Oceania journal of nuclear medicine & biology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

[<sup>18</sup>F]FDG PET/CT volumetric biomarkers for non-invasive prediction of HER2 expression in breast cancer patients.

Asia Oceania journal of nuclear medicine & biology

相似文献

Asia Oceania journal of nuclear medicine & biology

相关期刊

检索历史清除